FDA Priority Review Voucher Redemption Fee Set At $4.6 Million In Fiscal 2011
This article was originally published in The Pink Sheet Daily
Executive Summary
Users of the voucher, designed as an incentive for developing therapies for tropical diseases, will pay the fee on top of the standard $1.5 million PDUFA user fee.